BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17522328)

  • 1. Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector.
    Connell TG; Shey MS; Seldon R; Rangaka MX; van Cutsem G; Simsova M; Marcekova Z; Sebo P; Curtis N; Diwakar L; Meintjes GA; Leclerc C; Wilkinson RJ; Wilkinson KA
    Clin Vaccine Immunol; 2007 Jul; 14(7):847-54. PubMed ID: 17522328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Ex vivo stimulation of Mycobacterium tuberculosis-specific T cells by genetically detoxified Bordetella pertussis adenylate cyclase antigen toxoids.
    Wilkinson KA; Simsova M; Schölvinck E; Sebo P; Leclerc C; Vordermeier HM; Dickson SJ; Brown JR; Davidson RN; Pasvol G; Levin M; Wilkinson RJ
    Infect Immun; 2005 May; 73(5):2991-8. PubMed ID: 15845506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans.
    Rangaka MX; Diwakar L; Seldon R; van Cutsem G; Meintjes GA; Morroni C; Mouton P; Shey MS; Maartens G; Wilkinson KA; Wilkinson RJ
    Clin Infect Dis; 2007 Jun; 44(12):1639-46. PubMed ID: 17516410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of mycobacterial antigens delivered by genetically detoxified Bordetella pertussis adenylate cyclase by T cells from cattle with bovine tuberculosis.
    Vordermeier HM; Simsova M; Wilkinson KA; Wilkinson RJ; Hewinson RG; Sebo P; Leclerc C
    Infect Immun; 2004 Nov; 72(11):6255-61. PubMed ID: 15501751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.
    El Azami El Idrissi M; Ladant D; Leclerc C
    Toxicon; 2002 Dec; 40(12):1661-5. PubMed ID: 12457876
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
    Simsova M; Sebo P; Leclerc C
    Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.
    Arend SM; Engelhard AC; Groot G; de Boer K; Andersen P; Ottenhoff TH; van Dissel JT
    Clin Diagn Lab Immunol; 2001 Nov; 8(6):1089-96. PubMed ID: 11687445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
    Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
    EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.
    Day CL; Mkhwanazi N; Reddy S; Mncube Z; van der Stok M; Klenerman P; Walker BD
    J Infect Dis; 2008 Apr; 197(7):990-9. PubMed ID: 18419535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.
    Cheung GY; Xing D; Prior S; Corbel MJ; Parton R; Coote JG
    Infect Immun; 2006 Dec; 74(12):6797-805. PubMed ID: 16982827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay.
    Davies MA; Connell T; Johannisen C; Wood K; Pienaar S; Wilkinson KA; Wilkinson RJ; Zar HJ; Eley B; Beatty D; Curtis N; Nicol MP
    AIDS; 2009 May; 23(8):961-969. PubMed ID: 19287300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes.
    Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
    J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells.
    Chapman AL; Munkanta M; Wilkinson KA; Pathan AA; Ewer K; Ayles H; Reece WH; Mwinga A; Godfrey-Faussett P; Lalvani A
    AIDS; 2002 Nov; 16(17):2285-93. PubMed ID: 12441800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of
    Badami GD; La Manna MP; Di Carlo P; Stanek O; Linhartova I; Caccamo N; Sebo P; Dieli F
    Front Immunol; 2023; 14():1289212. PubMed ID: 38106407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study.
    Vincenti D; Carrara S; Butera O; Bizzoni F; Casetti R; Girardi E; Goletti D
    Clin Exp Immunol; 2007 Oct; 150(1):91-8. PubMed ID: 17680823
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.